Minimed Group, Inc. (MMED)
| Market Cap | 4.48B |
| Revenue (ttm) | 2.89B +28.6% |
| Net Income | -211.00M |
| EPS | n/a |
| Shares Out | 280.81M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 793,950 |
| Open | 15.90 |
| Previous Close | 15.76 |
| Day's Range | 15.55 - 16.24 |
| 52-Week Range | 15.18 - 20.48 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MMED
Minimed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems f... [Read more]
Financial Performance
In fiscal year 2025, Minimed Group's revenue was $2.72 billion, an increase of 9.96% compared to the previous year's $2.47 billion. Losses were -$213.00 million, 90.2% more than in 2024.
Financial StatementsNews
MiniMed announces closing of Initial Public Offering
NORTHRIDGE, Calif., March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,000 shares...
U.S. IPO Weekly Recap: Diabetes Medtech MiniMed Slides 8% In A Quiet Week For IPOs
The March IPO market started off with a quiet week. MiniMed Group completed the week's sole IPO, joined by two SPACs, and just one small issuer joined the pipeline. One large IPO and one direct listin...
MiniMed Group: Medtronic's Diabetes Business Does Not Convince
MiniMed Group trades at a modest 2x sales but struggles with persistent operating losses despite 10-15% annual revenue growth. The IPO priced below range at $20/share, raising $560M; Medtronic retains...
Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut
Shares of MiniMed , the diabetes business of medical device maker Medtronic , opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion.
MiniMed to begin trading on Nasdaq Global Select Market
GALWAY, Ireland, March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Na...
MiniMed begins trading on Nasdaq Global Select Market
NORTHRIDGE, Calif., March 6, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trading on the Nasdaq Global Select Market (Nasdaq) to...
Medtronic's diabetes unit MiniMed raises $560 million in US IPO
MiniMed, the diabetes business of medical device maker Medtronic , said on Thursday it has raised $560 million in its U.S. initial public offering.
Medtronic's MiniMed aims to raise $784 million in US IPO
Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.
U.S. IPO Weekly Recap: IPO Market Stays Fairly Quiet During The Short Holiday Week
One small issuer and four blank check companies went public this past week as the IPO market continued to weather the recent volatility. No deals are currently on the calendar for the week ahead, alth...
Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus
GALWAY, Ireland, Jan. 7, 2026 /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (...
U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week
Seven IPOs and two SPACs submitted filings this week; no pricings this week. The IPO calendar looks quiet for the week ahead, with one small issuer tentatively slated to debut. Street research is expe...
MiniMed Group Files For IPO In Medtronic Carve-Out
MiniMed Group, Inc., a Medtronic subsidiary, is targeting an IPO to fund growth and working capital amid diabetes device market expansion. MMED is well-positioned in automated insulin delivery, boasti...
Medtronic Spin-Off MiniMed Files for IPO
Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will oper...
Medtronic's MiniMed files for US IPO
MiniMed Group, the diabetes business of medical device maker Medtronic , filed for an initial public offering in the United States on Friday.
MiniMed Group IPO Registration Document (S-1)
MiniMed Group has filed to go public with an IPO on the NASDAQ.